FORNI, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 38.197
EU - Europa 20.873
AS - Asia 16.616
SA - Sud America 2.288
Continente sconosciuto - Info sul continente non disponibili 468
AF - Africa 424
OC - Oceania 48
Totale 78.914
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.567
GB - Regno Unito 6.632
IT - Italia 4.891
SG - Singapore 4.611
CN - Cina 4.550
SE - Svezia 3.766
HK - Hong Kong 2.100
BR - Brasile 1.701
VN - Vietnam 1.674
DE - Germania 1.143
TR - Turchia 812
UA - Ucraina 803
FI - Finlandia 735
RU - Federazione Russa 709
FR - Francia 686
BD - Bangladesh 682
KR - Corea 544
IN - India 412
BG - Bulgaria 314
CA - Canada 300
NL - Olanda 204
AR - Argentina 181
MX - Messico 168
JP - Giappone 162
RO - Romania 151
IQ - Iraq 143
ZA - Sudafrica 133
ID - Indonesia 131
IE - Irlanda 129
ES - Italia 115
PL - Polonia 110
PK - Pakistan 98
EC - Ecuador 97
BE - Belgio 95
CO - Colombia 91
AE - Emirati Arabi Uniti 88
MY - Malesia 75
CH - Svizzera 66
VE - Venezuela 64
TH - Thailandia 63
CL - Cile 57
MA - Marocco 57
IR - Iran 52
DZ - Algeria 48
LT - Lituania 48
EG - Egitto 46
PH - Filippine 43
UZ - Uzbekistan 42
AU - Australia 40
SA - Arabia Saudita 40
CZ - Repubblica Ceca 37
IL - Israele 37
PT - Portogallo 37
JO - Giordania 36
NP - Nepal 36
PE - Perù 35
TN - Tunisia 34
PY - Paraguay 31
AT - Austria 28
JM - Giamaica 28
KE - Kenya 28
TW - Taiwan 26
AZ - Azerbaigian 25
GR - Grecia 23
EU - Europa 20
KZ - Kazakistan 20
CR - Costa Rica 19
SN - Senegal 19
DO - Repubblica Dominicana 17
ET - Etiopia 17
MD - Moldavia 17
TT - Trinidad e Tobago 17
BO - Bolivia 16
DK - Danimarca 16
AL - Albania 14
HN - Honduras 14
UY - Uruguay 14
LB - Libano 13
OM - Oman 13
BY - Bielorussia 12
RS - Serbia 12
HU - Ungheria 11
LV - Lettonia 10
NO - Norvegia 10
PA - Panama 10
GT - Guatemala 9
KG - Kirghizistan 9
NI - Nicaragua 9
EE - Estonia 8
HR - Croazia 8
NZ - Nuova Zelanda 8
BH - Bahrain 7
CY - Cipro 7
MN - Mongolia 7
PR - Porto Rico 7
PS - Palestinian Territory 7
SI - Slovenia 7
SV - El Salvador 7
AM - Armenia 6
AO - Angola 6
Totale 78.333
Salva come PNG Salva come JPEG
Città #
Southend 5.220
Ashburn 3.614
Santa Clara 3.470
Singapore 2.890
Fairfield 2.618
Chandler 2.172
Hong Kong 2.062
Woodbridge 1.903
Stockholm 1.816
Jacksonville 1.624
Hefei 1.444
San Jose 1.433
Houston 1.329
Chicago 1.277
Dearborn 1.215
Wilmington 1.108
Seattle 1.069
Nyköping 1.060
Ann Arbor 1.050
Council Bluffs 996
Beijing 902
Cambridge 889
Los Angeles 818
London 736
Ho Chi Minh City 545
Modena 486
Izmir 465
Seoul 462
Milan 443
Helsinki 441
The Dalles 440
Hanoi 398
New York 393
Salt Lake City 337
Princeton 324
Sofia 301
Eugene 276
Dallas 263
Des Moines 251
Buffalo 246
San Diego 241
Rome 235
Lauterbourg 231
Moscow 182
Redwood City 180
Shanghai 160
Columbus 154
São Paulo 147
Bremen 146
Tampa 144
Elk Grove Village 135
Orem 133
Tokyo 121
Munich 118
Dublin 108
Fremont 104
Boardman 98
Bologna 98
Naples 98
Phoenix 96
Frankfurt am Main 94
Chennai 86
Brussels 82
Lancaster 77
Falls Church 76
Guangzhou 76
Jakarta 70
Da Nang 69
Johannesburg 65
Sterling 65
Miami 63
Haiphong 62
Toronto 62
Atlanta 61
Warsaw 61
Washington 61
Florence 58
Parma 58
Brooklyn 57
Denver 55
Norwalk 54
Montreal 53
Turin 53
Baghdad 50
Bari 49
Como 49
Nanjing 48
Amsterdam 47
Detroit 47
Dulles 47
Mexico City 47
Miano 46
Kunming 45
Catania 44
Charlotte 43
Reggio Emilia 43
Rio de Janeiro 43
Mumbai 41
Belo Horizonte 40
Napoli 39
Totale 54.001
Salva come PNG Salva come JPEG
Nome #
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 2.338
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 603
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 521
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 519
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 500
Cristallinità ed equivalenza nel cloramfenicolo palmitato 499
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 474
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 470
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 463
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 454
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 444
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 435
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 428
Cationic liposomes for gene transfection 427
NUTRASCIENCE s.r.l. 427
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 427
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 426
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 425
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 420
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 415
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 414
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 412
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 408
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 404
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 404
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 398
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 393
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 390
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 387
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 382
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 380
Polymeric nanoparticles for the drug delivery to the central nervous system 379
Nanoparticle transport across the blood brain barrier 375
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 374
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 373
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 372
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 371
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 369
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 369
Distribution of drugs in polymers loaded by swelling 368
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 368
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 366
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 364
Protein corona and nanoparticles: How can we investigate on? 363
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 354
Diffusione di derivati dell\'acido benzoico attraverso membrane lipidiche in presenza di Tween 80 354
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 353
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 352
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 351
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 351
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 349
Microwave-treated gelatin microspheres as drug delivery system 348
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 345
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 345
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 344
Biodisponibilità e bioequivalenza in compresse commerciali di nitrofurantoina 342
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 341
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 340
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 340
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 339
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 339
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 337
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 337
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 337
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 336
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 334
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 334
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 331
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 330
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 330
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 329
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 329
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 328
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 328
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 328
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 327
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 326
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 325
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 323
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 322
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 322
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 322
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 318
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 316
Functionalization of liposomes: microscopical methods for preformulative screening 314
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 313
Colloidal systems for CNS drug delivery 311
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 311
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 310
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 304
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 303
Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence 303
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 302
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 298
Pseudomorfosi nel cloramfenicolo stearato e palmitato in relazione alla disponibilità 297
AN INTERPRETATIVE ANALYSIS OF THE EFFECT OF THE SURFACTANTS USED FOR THE PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES ON THE RELEASE PROCESS 296
A solution and solid state study on 2-hydroxypropyl-beta-cyclodextrin complexation with hyodeoxycholic acid 295
Papaverine hydrochloride release from ethyl cellulose-walled microcapsules 294
Activitè enzymatique de la pancréatine de formes pharmaceutiques: une nouvelle méthode d'évaluation 294
Solid state transitions and CAP availability in surface solid dispersions of chloramphenicol stearate polymorphs 292
Totale 38.571
Salva come PNG Salva come JPEG
Categoria #
all - tutte 284.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 284.056
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.423 0 0 486 430 173 261 274 296 604 387 871 641
2022/20236.271 749 683 534 609 764 980 160 525 673 96 225 273
2023/20243.890 185 227 226 295 816 391 468 527 138 118 173 326
2024/202512.486 647 183 264 943 2.567 1.738 895 819 1.177 476 1.302 1.475
2025/202624.442 1.437 785 1.782 2.776 4.171 1.590 2.383 1.060 4.114 2.108 1.245 991
2026/20272.083 523 1.426 134 0 0 0 0 0 0 0 0 0
Totale 78.914